Cargando...
Oncolytic viruses: From bench to bedside with a focus on safety
Oncolytic viruses are a relatively new class of anti-cancer immunotherapy agents. Several viruses have undergone evaluation in clinical trials in the last decades, and the first agent is about to be approved to be used as a novel cancer therapy modality. In the current review, an overview is present...
Gardado en:
| Publicado en: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514197/ https://ncbi.nlm.nih.gov/pubmed/25996182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1037058 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|